Breaking News

Octapharma Supports New COVID-19 Trial

Aims to assess if Intravenous Immunoglobulin (IVIG) can halt coronavirus progression to respiratory failure

By: Contract Pharma

Contract Pharma Staff

Octapharma USA is supporting a new investigator initiated clinical trial led by George Sakoulas, M.D. of Sharp Memorial Hospital in San Diego, CA focused on treating the most critical patients with coronavirus experiencing respiratory failure who become ventilator dependent. The trial is entitled Randomized Open Label Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection. Dr. Sakoulas, an infectious disease c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters